End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.35 TWD | +4.05% | +6.41% | -34.95% |
May. 28 | Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index | CI |
May. 13 | Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 167
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 22 | 100.0 % | 61 | 100.0 % | +174.11% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
87.4
%
| 22 | 100.0 % | 54 | 87.4 % | +139.70% |
United States
12.6
%
| 0 | 0.0 % | 8 | 12.6 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kuan Hao Lin
DFI | Director of Finance/CFO | - | 22-02-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
ALLEN Chao
FOU | Founder | 78 | 13-05-07 |
Ta Meng Tseng
BRD | Director/Board Member | 66 | 13-10-05 |
Chih Chuan Chen
BRD | Director/Board Member | - | 13-10-05 |
Tai Chang Wang
BRD | Director/Board Member | 65 | 21-08-26 |
Chin Pao Tsai
BRD | Director/Board Member | - | 15-05-14 |
Lin Zheng Chen
CEO | Chief Executive Officer | - | 15-05-14 |
Cheng Hsia
BRD | Director/Board Member | - | 15-05-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 164,026,867 | 98,110,867 ( 59.81 %) | 0 | 59.81 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-34.95% | 214M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- 6541 Stock
- Company Tanvex BioPharma, Inc.